Attention-deficit/hyperactivity disorder: the road traveled and the road ahead.
Jun
Allison
A
D019969:Amphetamine-Related Disorders / Q000209:etiology; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000503:physiopathology; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D003913:Dextroamphetamine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D000069478:Lisdexamfetamine Dimesylate
D000697:Central Nervous System Stimulants; D000069478:Lisdexamfetamine Dimesylate; D003913:Dextroamphetamine